.-We studied the functions of ␤␥-subunits of Gi/o protein using the Xenopus oocyte expression system. Isoproterenol (ISO) elicited cAMP production and slowly activating Cl Ϫ currents in oocytes expressing ␤2-adrenoceptor and the protein kinase A-dependent Cl , and baclofen enhanced ISO-induced cAMP levels and CFTR currents in oocytes expressing ␤2-adrenoceptor-CFTR and 5-HT1A receptor (5-HT1AR), ␦-opioid receptor, or GABAB receptor, respectively. 5-HT also enhanced pituitary adenylate cyclase activating peptide (PACAP) 38-induced cAMP levels and CFTR currents in oocytes expressing PACAP receptor, CFTR and 5-HT1AR. The 5-HT-induced enhancement of Gs-coupled receptormediated currents was abrogated by pretreatment with pertussis toxin (PTX) and coexpression of G transducin ␣ (Gt␣). The 5-HT-induced enhancement was further augmented by coexpression of the G␤␥-activated form of adenylate cyclase (AC) type II but not AC type III. Thus ␤␥-subunits of Gi/o protein contribute to the enhancement of Gs-coupled receptor-mediated responses. 5-HT and DADLE did not elicit any currents in oocytes expressing 5-HT1AR or ␦-opioid receptor alone. They elicited Ca 2ϩ -activated Cl Ϫ currents in oocytes coexpressing these receptors with the G␤␥-activated form of phospholipase C (PLC)-␤2 but not with PLC-␤1. These currents were inhibited by pretreatment with PTX and coexpression of Gt␣, suggesting that ␤␥-subunits of Gi/o protein activate PLC-␤2 and then cause intracellular Ca 2ϩ mobilization. Our results indicate that ␤␥-subunits of Gi/o protein participate in diverse intracellular signals, enhancement of Gs-coupled receptor-mediated responses, and intracellular Ca 2ϩ mobilization.
G protein-coupled receptor; cystic fibrosis transmembrane conductance regulator gene; cross talk; electrophysiology STIMULATION OF G PROTEIN-COUPLED RECEPTORS activates diverse intracellular signaling pathways and a variety of cellular functions that are dependent on the coupling of a set of G protein families, among which G i/o -coupled receptors are known to activate a variety of effectors (20, 21) . Although stimulation of G i/o -coupled receptors is generally considered to inhibit the accumulation of cAMP in most cells, activation of these receptors, including GABA B receptor (12, 14, 30) , dopamine D 2 receptor (9), and ␣ 2 -adrenoceptor (23) , enhance cAMP production mediated by G s -coupled receptors such as ␤ 2 -adrenoceptor and vasoactive intestinal peptide receptor. Using a protein kinase A-mediated Cl Ϫ channel encoded by the cystic fibrosis transmembrane conductance regulator (CFTR) gene as an electrophysiological sensor for cAMP changes, investigators at our laboratory (29) previously demonstrated that activation of GABA B receptors enhances cAMP production induced by G s -coupled receptors. It has been established that increased Cl Ϫ current through CFTR is correlated to increased cAMP level in Xenopus oocytes (28) .
It is well known that the ␤␥-subunits of G protein regulate the activities of several types of effectors, including phospholipase C (PLC), adenylate cyclases (AC), phosphatidylinositol 3-kinases, G protein-coupled receptor kinases, and some ion channels (4, 20, 25) . Although G␤␥-subunits are members of all trimeric G proteins, it is generally accepted that high concentrations of free G␤␥-subunits in the cells arise from G i/o proteins, which are abundantly expressed in the cells compared with other G proteins (20, 25) . Thus it is important to elucidate whether the G␤␥-subunits released from G i/o proteins regulate the activity of various effectors.
The present study was designed to elucidate the involvement of G␤␥-subunits released from G i/o protein in the diverse intracellular signaling pathways. In particular, we focused on the involvement of cAMP signaling and intracellular Ca 2ϩ signaling pathways. To this end, using an electrophysiological assay as well as a cAMP assay with the Xenopus oocyte expression system, we examined whether a set of cloned G i/o -coupled receptors regulate such signaling pathways.
MATERIALS AND METHODS
Drugs and chemicals. Isoproterenol (ISO), 5-hydroxytryptamine (5-HT), baclofen, gentamicin, pertussis toxin (PTX), sodium pyruvate, and niflumic acid were purchased from Sigma (St. Louis, MO).
[D-Ala 2 , D-Leu 5 ]-enkephalin (DADLE) and pituitary adenylate cyclase activating peptide (PACAP) 38 were obtained from Osaka Peptide Institute (Osaka, Japan). All other chemicals used were of analytical grade and were obtained from Nacalai Tesuque (Kyoto, Japan)
Preparation of cRNA. cDNA from the human CFTR gene was provided by Dr. J. R. Riordan (Mayo Clinic, Scottsdale, AZ). AC type II was obtained from Dr. R. Reed (The Johns Hopkins University, Baltimore, MD), and AC type III was supplied by Dr. K. G. Zinn (California Institute of Technology, Pasadena, CA). Rat PACAP receptor was obtained from Dr. A. Arimura (Tulane University, New Orleans, LA). Rat 5-HT 1A receptor (5-HT1AR) and 5-HT2CR, ␤2-adrenoceptor, and ␦-opioid receptor were kindly provided by Dr. H. A. Lester (California Institute of Technology). Rat phospholipase C-␤1 (PLC-␤1) and PLC-␤2 were obtained from Dr. S. G. Rhee (National Heart, Lung, and Blood Institute, Bethesda, MD). GABA B(1b) and GABAB2 receptors were supplied by Dr. N. J. Fraser (GlaxoWellcome Research and Development, Stevenage, UK). Each cRNA was synthesized from the respective linearized cDNA using a T7 or SP6 RNA polymerase kit (Ambion, Austin, TX).
Oocyte preparation and cRNA injection. Immature V and VI stage Xenopus oocytes were enzymatically dissociated as reported previously (28) . Isolated oocytes were incubated at 18°C in ND-96 medium (in mM: 96 NaCl, 2 KCl, 1 CaCl2, 1 MgCl2, and 5 HEPES, pH 7.4) containing 2.5 mM sodium pyruvate and 50 g/ml gentamicin. For measurement of CFTR currents induced by stimulation of Gs-coupled receptors, cRNA for CFTR (4 ng) and ␤2-adrenoceptor (0.1 ng) or PACAP receptor (1 ng) were injected into the oocytes together with or without 5-HT1AR (10 ng), ␦-opioid receptor (10 ng), GABAB(1b) receptor (10 ng), and GABAB2 receptor (10 ng). In some oocytes, cRNA for 5-HT2CR (1 ng), G transducin ␣ (Gt␣; 5 ng), AC type II (5 ng), AC type III (5 ng), PLC-␤1 (5 ng), or PLC-␤2 (25 ng) was injected. The final injection volume was Ͻ50 nl in all cases. Oocytes were incubated in ND-96 medium and used 3-8 days after injection.
Electrophysiological recordings. Electrophysiological recordings were performed using the two-electrode voltage-clamp method with a GeneClamp 500 amplifier (Axon Instruments, Foster, CA) at room temperature. Oocytes were clamped at Ϫ60 mV and continuously superfused with ND-96 medium in a 0.25-ml chamber at a flow rate of 5 ml/min, and test compounds were added to the superfusion solution. In experiments with niflumic acid, the compound was added 10 min before agonist stimulation and maintained throughout the experiment. Voltage-recording microelectrodes were filled with 3 M KCl and had a tip resistance of 1.0 -2.5 M⍀. Currents were continuously recorded and stored with Mac Lab software (AD Instruments, Castle Hill, Australia) on a Macintosh computer. The ramp protocol was performed as described previously (28) .
cAMP assay. The cellular cAMP level in individual oocytes was measured by conventional radioimmunoassay. Briefly, oocytes were washed three times with ND-96 buffer and preincubated with 1 mM IBMX for 30 min followed by another incubation with varying concentrations of ISO or other test compounds containing 1 mM IBMX and 1 mg/ml bovine serum albumin as described previously (31) . The reaction was stopped by the addition of 100 mM HCl followed by heating to 95°C for 5 min. The cAMP content of individual oocytes was assayed using a [
125 I]-labeled cAMP radioimmunoassay kit (Yamasa, Chiba, Japan).
Statistical analysis. Data are expressed as means Ϯ SE. Differences between two groups were examined for statistical significance using a paired t-test. For comparisons between multiple groups, we performed one-way analysis of variance followed by Scheffé's test. P Ͻ 0.05 denoted the presence of a statistically significant difference.
RESULTS

5-HT enhances ISO-induced CFTR currents. ISO at the concentrations of 10
Ϫ9
-10
Ϫ4 M elicited slowly activating inward currents in oocytes expressing a combination of ␤ 2 -adrenoceptor and CFTR, but not in noninjected oocytes, as shown previously by Uezono et al. (28) . ISO at a concentration of 10 Ϫ7 M, which corresponds to a 40 -50% effective concentration (EC) of the maximal responses, elicited CFTR Cl Ϫ currents in all oocytes expressing ␤ 2 -adrenoceptor and CFTR, regardless of the expression level of 5-HT 1A R (Fig. 1) . At a concentration of 10 Ϫ7 M, 5-HT did not elicit any currents in all oocytes that expressed 5-HT 1A R alone. Moreover, 5-HT did not elicit any currents in oocytes expressing 5-HT 1A R and ␤ 2 -adrenoceptor-CFTR (Fig. 1) . When 5-HT (10 Ϫ7 M) was applied simultaneously with ISO (10 Ϫ7 M), the ISO-induced CFTR currents were enhanced in oocytes that expressed ␤ 2 -adrenoceptor-CFTR and 5-HT 1A R (Fig. 1) . In noninjected oocytes, no endogenous responses to ISO, 5-HT, or both were noted, even at 10 Ϫ4 M (data not shown). The 5-HT-induced enhancement was concentration dependent, and the EC 50 of 5-HT was 2.9 Ϯ 0.31 ϫ 10 Ϫ8 M (Fig. 1C and Table 1 ), which was similar (ϳ1.6 ϫ 10 Ϫ8 M) to that activated in inward rectifying K ϩ channels in oocytes expressing 5-HT 1A R and G protein-activated inward rectifying K ϩ channels (6) .
DADLE and baclofen enhance ISO-induced CFTR currents.
In oocytes expressing ␤ 2 -adrenoceptor and CFTR, as well as ␦-opioid or GABA B receptors, ISO (10 Ϫ7 M) elicited CFTR currents in oocytes regardless of expression of ␦-opioid or GABA B receptor (Fig. 2) . DADLE (10 Ϫ7 M) and baclofen (10 Ϫ4 M) did not elicit any currents in oocytes expressing ␦-opioid receptor alone (see Fig. 8 ) or GABA B receptor alone (data not shown). These compounds also did not elicit any currents in oocytes expressing ␦-opioid or GABA B receptor and ␤ 2 -adrenoceptor-CFTR (Fig. 2 ). When DADLE (10 Ϫ7 M) or baclofen (10 Ϫ4 M) was applied simultaneously with ISO (10 Ϫ7 M), the ISO-induced CFTR currents were enhanced in oocytes that expressed ␤ 2 -adrenoceptor-CFTR and ␦-opioid or GABA B receptor (Fig. 2) , respectively. Baclofen (10 Ϫ4 M)-induced enhancement was noted in oocytes that expressed ␤ 2 -adrenoceptor-CFTR and a heterodimer of GABA B receptor [GABA B1(b) and GABA B2 ], but not in oocytes that expressed ␤ 2 -adrenoceptor-CFTR and GABA B1(b) receptor alone or GABA B2 receptor alone (Fig. 2) , confirming that functional GABA B receptors need heterodimerization (16) .
G i/o -coupled receptor agonists enhance ISO-induced cAMP production. ISO (10
Ϫ7 M) elevated cAMP production in oocytes expressing ␤ 2 -adrenoceptor, but not in the noninjected oocytes or in oocytes not expressing ␤ 2 -adrenoceptor (Fig. 3 , A-C). 5-HT, DADLE, and baclofen did not elevate cAMP production in oocytes expressing 5-HT 1A R, ␦-opioid receptor, and heterodimeric GABA B receptor together with or without ␤ 2 -adrenoceptor, respectively (Fig. 3 , A-C). In the oocytes expressing ␤ 2 -adrenoceptor together with 5-HT 1A R, ␦-opioid receptor, or heterodimeric GABA B receptor, simultaneous application of 5-HT, DADLE, or baclofen with ISO, but not individual application, enhanced ISO-induced cAMP production (Fig. 3, A-C) . The EC 50 values of 5-HT, DADLE, and baclofen in the enhancement of ISO-induced cAMP production were almost similar to those for the enhancement of ISOinduced CFTR currents (Table 1) .
5-HT enhances PACAP-induced cAMP production and CFTR currents. We next examined whether cAMP production and CFTR currents activated by another G s -coupled receptor were also enhanced by G i/o -coupled receptor activation. PACAP38 (10 Ϫ7 M), an agonist of PACAP receptor, elicited cAMP production and CFTR currents in oocytes that expressed PACAP receptor and CFTR together with or without 5-HT 1A R (Fig. 4, A and B) . 5-HT did not elicit cAMP production or any currents in oocytes expressing PACAP-CFTR and 5-HT 1A R (Fig. 4) . Simultaneous application of 5-HT (10 Ϫ7 M) and PACAP38 (10 Ϫ7 M) enhanced the PACAP-induced responses in oocytes expressing PACAP-CFTR and 5-HT 1A R (Fig. 4) .
The EC 50 of 5-HT on cAMP production and CFTR currents caused by 10 Ϫ7 M PACAP38 were 1.4 Ϯ 0.08 ϫ 10 Ϫ8 M and 2.1 Ϯ 0.14 ϫ 10 Ϫ8 M, respectively (n ϭ 3 at each concentration as described in Table 1 ). DADLE (10 Ϫ7 M) and baclofen (10 Ϫ4 M) also enhanced CFTR currents induced by PACAP38 (10 Ϫ7 M) in oocytes expressing PACAP-CFTR and ␦-opioid receptors or heterodimeric GABA B receptors (235 Ϯ 12 or 248 Ϯ 14% of the currents with 10 Ϫ7 M ISO alone, respectively; n ϭ 3 at each concentration as described in Table 1) .
PTX abrogates 5-HT-induced enhancement of ISO-or PACAP38-induced CFTR currents. Signaling pathways through G i or G o proteins are known to be interrupted by treatment with PTX (9) . To determine the G proteins responsible for 5-HT-induced enhancement of CFTR currents, oocytes expressing ␤ 2 -adrenoceptor-CFTR and 5-HT 1A R, or oocytes expressing PACAP-CFTR and 5-HT 1A R, were pretreated with PTX (2 g/ml) for 16 h. The concentration and duration used in our experiment were previously reported to almost completely inactivate the G i/o protein in oocytes (28, 29) . ISO (10 Ϫ7 M) and PACAP38 (10 Ϫ7 M) elicited CFTR currents of almost the same amplitude in oocytes pretreated with or without PTX (Fig. 5 ). When 5-HT (10 Ϫ7 M) was applied simultaneously with ISO or PACAP38, the responses to these substances were enhanced in nontreated oocytes but not in PTXtreated oocytes (Fig. 5) . Similar responses were observed in oocytes that expressed ␤ 2 -adrenoceptor-CFTR and ␦-opioid receptor; treatment with PTX abrogated the enhanced effects of DADLE on the ISO-induced CFTR currents (data not shown).
G t ␣ abrogates 5-HT-induced enhancement of ISO-induced CFTR currents.
To analyze the role of G␤␥-subunits in 5-HTinduced enhancement, we investigated the effect of coexpression of G t ␣, a scavenger of ␤␥-subunits released from G proteins (9, 13) , in oocytes expressing ␤ 2 -adrenoceptor-CFTR and 5-HT 1A R. When 5-HT (10 Ϫ7 M) was applied simultaneously with ISO (10 Ϫ7 M), the 5-HT-induced enhancement of ISO-induced currents was suppressed in oocytes coexpressing G t ␣ but was still observed in oocytes lacking the expression of G t ␣ (Fig. 6) . The same results were recorded in oocytes expressing ␤ 2 -adrenoceptor-CFTR and ␦-opioid receptor; the DADLE-induced enhancement of ISO-induced currents was suppressed by coexpression of G t ␣ (data not shown).
Effects of AC types II and III on 5-HT-induced enhancement of ISO-activated currents.
The 5-HT-induced enhancement of ISO-activated currents was compared between coexpression of AC types II and III in oocytes expressing ␤ 2 -adrenoceptor-CFTR and 5-HT 1A R. Coexpression of the G␤␥-subunit-activated form of AC type II (27) further augmented 5-HT-induced enhancement of ISO (10 Ϫ7 M)-activated currents. On the other hand, coexpression of the G␤␥-subunit-insensitive form of AC type III did not affect 5-HT-induced enhancement of ISO (10 Ϫ7 M)-mediated responses (Fig. 7) . Expression of these AC in oocytes was confirmed by the fact that expression of AC types II and III enhanced CFTR currents induced by forskolin, a direct activator of AC [data not shown and Uezono et al. (28) ] i ) in certain types of cells, such as that of G q -coupled receptors (20, 25) . To further elucidate the involvement of G␤␥-subunits in Ca 2ϩ mobilization induced by G i/o -coupled receptors, we expressed PLC-␤2, an isotype known to be activated by G␤␥-subunits in oocytes. As a control, we expressed G q -coupled 5-HT 2c R, known to elevate [Ca 2ϩ ] i , which in turn activates Ca 2ϩ -activated Cl Ϫ channels endogenously expressed in Xenopus oocytes (24) . Application of 5-HT (10 Ϫ7 M) elicited Ca 2ϩ -activated Cl Ϫ currents in oocytes expressing 5-HT 2C R, as reported previously (24) (Fig. 8) . 5-HT and DADLE at concentrations up to 10 Ϫ3 or 10 Ϫ5 M, respectively, did not elicit any currents in oocytes expressing 5-HT 1A R or ␦-opioid receptor alone. On the other hand, in oocytes expressing 5-HT 1A R or ␦-opioid receptor together with PLC-␤2, both 5-HT (10 Ϫ7 M) and DADLE (10 Ϫ7 M) elicited inward currents. The current displayed a reversal potential of approximately Ϫ25 mV, which is composed of Cl Ϫ currents, in terms of ramp protocol from Ϫ80 to ϩ80 mV [ Fig. 8C 
; right: summary of CFTR currents. Each bar represents the mean Ϯ SE of peak CFTR currents expressed as %isoproterenol-induced peak currents from each of 6 oocytes. *P Ͻ 0.05.
8), although 5-HT (10
Ϫ7 M) caused significantly greater Cl Ϫ currents in oocytes expressing 5-HT 2c R and PLC-␤1 than in those expressing 5-HT 2c R alone (Fig. 8) , possibly because of G q ␣-mediated activation of PLC-␤1. To further investigate the role of G␤␥-subunit released from G i/o proteins, oocytes expressing 5-HT 1A R or ␦-opioid receptor with PLC-␤2 were M), or baclofen (10 Ϫ4 M) was applied for 10 min as indicated. A: 5-HT enhances isoproterenol-induced cAMP production in oocytes expressing both ␤2-adrenoceptor and 5-HT1AR. B: DADLE enhances isoproterenol-induced cAMP production in oocytes expressing both ␤2-adrenoceptor and ␦-opioid receptors. C: baclofen enhances isoproterenol-induced cAMP production in oocytes expressing both ␤2-adrenoceptor and heterodimeric GABAB receptor. Each bar represents the mean Ϯ SE of cAMP levels in the oocytes. *P Ͻ 0.05. n.s., Not significant. pretreated with PTX or coexpressed with G t ␣ as described in Figs. 5 and 6. As expected, the currents caused by 5-HT or DADLE were completely inhibited by PTX pretreatment or suppressed by coexpression of G t ␣ (Fig. 9) .
DISCUSSION
In the present study, we investigated signaling pathways activated by a set of cloned G i/o -coupled receptors using electrophysiological assays as well as cAMP assay in the Xenopus oocyte expression system. ISO elicited cAMP production and Cl Ϫ currents through CFTR channels in oocytes expressing a combination of ␤ 2 -adrenoceptor and CFTR. In oocytes expressing ␤ 2 -adrenoceptor-CFTR and G i/o -coupled receptors such as 5-HT 1A R, ␦-opioid receptor, and GABA B receptors, application of 5-HT, DADLE, or baclofen together with ISO enhanced ISO-induced cAMP production and CFTR currents. CFTR currents and cAMP production elicited by another G s -coupled receptor, PACAP receptor, were also enhanced by 5-HT in oocytes expressing PACAP receptor and CFTR together with 5-HT 1A R. CFTR has been reported to be regulated by several intracellular second messengers, such as cGMP-dependent protein kinases, protein kinase C, or tyrosine kinases, as well as cAMP-dependent protein kinases (26) . In 5-HT1AR) . B: summary of effects of PTX pretreatment on CFTR currents. Each bar represents the mean Ϯ SE of peak CFTR currents expressed as %isoproterenol-or %PACAP38-induced peak currents from each of 6 oocytes. *P Ͻ 0.05 vs. isoprotenerol alone. #P Ͻ 0.05 vs. PACAP38 alone. our study, because the amplitude of the CFTR currents correlates well to changes in cAMP level in Xenopus oocytes in the present study and previous studies conducted in our laboratory (Table 1 and Refs. 28 and 29), cAMP-dependent protein kinases mostly contributed to the regulation of CFTR in our experimental system. From the results of CFTR currents and cAMP production, we conclude that G s -coupled receptor-mediated cAMP-dependent cellular processes could be enhanced by simultaneous activation of G i/o -coupled receptors.
Stimulation of G i/o -coupled receptors is generally considered to inhibit cAMP accumulation in most cells. On the other hand, stimulation of G i/o -coupled receptors, including GABA B receptor, dopamine D 2 receptor, or ␣ 2 adrenoceptor, has been shown to enhance cAMP production induced by G s -coupled receptors such as ␤ 2 -adrenoceptor and vasoactive intestinal peptide receptor (9, 12, 23, 30) . Some G i/o -coupled receptors, including opioid receptor, ␣ 2 -adrenoceptor, muscarinic M 4 receptor, and cannabinoid CB 1 receptor, are coupled not only to G i/o protein but also to G s protein and are known to stimulate cAMP production (5, 7, 8, 11) . We have shown in this study that 5-HT-induced enhancement of ISO-and PACAP38-mediated responses was abrogated by pretreatment with PTX in oocytes expressing CFTR, ␤ 2 -adrenoceptor, or PACAP receptor together with 5-HT 1A R. Because PTX interrupts signaling pathways from G i/o -coupled receptors to G i/o proteins without affecting G s protein-mediated responses (9), we conclude that G i/o proteins, but not G s proteins, are involved in such enhancement.
Because ␤␥-subunits of G protein regulate the activities of several types of effectors, including PLC, AC, and some ion channels (4, 20) , we investigated whether the ␤␥-subunits of G i/o protein contribute to the enhancement of responses mediated by G s -coupled receptors. G t ␣ has been shown to inhibit downstream signaling through G␤␥-subunits by sequestering free ␤␥-subunits (9) . We previously demonstrated that G i/ocoupled cannabinoid CB 1 and CB 2 receptors activated inward rectifying K ϩ channels through G␤␥-subunits by showing that these effects were inhibited by coexpression of G t ␣ (13). Our results also showed that coexpression of G t ␣ prevented 5-HTinduced enhancement of CFTR currents caused by ISO, suggesting that G␤␥-subunits released by G i/o -coupled receptor stimulation caused the enhancement of G s -coupled receptormediated cAMP production. cAMP is produced by activation of AC, and to date, eight types of AC genes have been cloned, each of which is differentially regulated by G s ␣, G␤␥, Ca 2ϩ / calmodulin, protein kinase C, and [Ca 2ϩ ] i (27) . The ␤␥-subunits are known to activate AC types II and IV, but not AC type III, in the presence of activated G s ␣ (19, 27) . In agreement with these reports, our results showed that enhancement of 5-HT-induced CFTR currents was augmented by coexpression of AC type II, but not AC type III, in oocytes expressing ␤ 2 -adrenoceptor-CFTR and 5-HT 1A R. Thus ␤␥-subunits released by activation of G i/o -coupled receptors contribute to the enhancement of G s -coupled receptor-mediated responses, presumably by the activation of AC type II or IV present in oocytes. Collectively, these findings demonstrate that activation of G i/o -coupled receptors enhance the cAMP production induced by G s -coupled receptors through G␤␥-subunits released from PTX-sensitive G i/o proteins.
We also have demonstrated that ␤␥-subunits released by activation of G i/o -coupled receptors appear to be involved in another signaling pathway, the Ca 2ϩ mobilization signaling pathway. We have clearly shown that 5-HT or DADLE elicited Ca 2ϩ -activated Cl Ϫ currents in oocytes expressing 5-HT 1A R or ␦-opioid receptor together with PLC-␤2. It has been shown that G␤␥-subunits activate PLC-␤2, but not PLC-␤1, in cotransfection assays with COS-7 cells (15) . As such, substitution of PLC-␤1 for PLC-␤2 in the coexpression did not elicit Ca 2ϩ -activated Cl Ϫ currents induced by 5-HT or DADLE in oocytes expressing 5-HT 1A R or ␦-opioid receptor, respectively. In Xenopus oocytes, G␤␥-subunit-sensitive PLC-␤-like proteins, namely, PLC-␤X, were present (10) . Accordingly, G␤␥ liberated by activation of G i/o -coupled receptors may increase [Ca 2ϩ ] i through activation of endogenously expressed PLC-␤X in oocytes. In fact, 5-HT elicited Ca 2ϩ -activated Cl Ϫ currents without additional expression of PLC-␤2 or -␤3 in oocytes expressing cloned 5-HT 1A receptor in the vector, which was designed to overexpress the receptor in oocytes (22) . However, we found it necessary to express PLC-␤2 to elicit G i/o -coupled receptor-mediated Ca 2ϩ -activated Cl Ϫ currents, including 5-HT 1A R, ␦-opioid receptor, cannabinoid CB 1 and CB 2 receptors, and functional GABA B receptors (present study and unpublished observations). The reason for the differences between the results of other investigators and ours is not known at present. It could be the expression levels of cell surface receptors in Xenopus oocytes; extremely overexpressed receptors may liberate G␤␥-subunits sufficiently to activate endogenous PLC-␤X.
We have further demonstrated that 5-HT 1A R-and ␦-opioid receptor-mediated Ca 2ϩ -activated Cl Ϫ currents were suppressed by pretreatment with PTX and by coexpression of G t ␣. These findings suggest that ␤␥-subunits released by activation of G i/o -coupled receptors could activate PLC-␤2 and then stimulate intracellular Ca 2ϩ mobilization. A recent study (34) in Xenopus oocytes showed that G␤␥-subunits caused direct activation of inositol 1,4,5-trisphosphate (IP 3 ) receptors in addition to activation of PLC-␤, and both pathways consequently increased [Ca 2ϩ ] i . However, it may be less likely that G␤␥-subunits liberated by 5-HT 1A R or ␦-opioid receptor stimulation directly activated IP 3 receptors to increase in [Ca 2ϩ ] i in our experimental condition, because exogenously expressed PLC-␤2 was required to elicit Ca 2ϩ -activated Cl Ϫ currents. Nonetheless, further detailed studies are necessary to clarify the involvement of this novel signaling pathway in G i/o -coupled receptor-mediated Ca 2ϩ mobilization in the Xenopus oocyte and also in the mammalian cell expression systems.
The present study demonstrates that the ␤␥-subunits released from G i/o proteins participate in diverse signal pathways such as enhancement of the G s -coupled receptor-mediated cAMP system and mobilization of [Ca 2ϩ ] i , provided that a set of particular effectors, such as AC type II or PLC-␤2, is present in the cells. The number of G protein subunits identified to date includes 27 subunits of G␣, 5 of G␤, and 14 of G␥ (1) . As expected, various combinations of G␤ and G␥ are possible, and they appear to lead to a diversity of cellular functions. Using the G␤ and G␥ subunit reconstitution assay, investigators in several studies have examined cellular functions mediated by particular combinations of G␤␥-subunits. For instance, the G␤ 1 ␥ 2 subunit activates, but the G␤ 5 ␥ 2 subunit inhibits, AC type II (2); the G␤ 5 ␥ 2 subunit activates PLC-␤1 and PLC-␤2 (18); and all combinations of G␤ 1-5 ␥ 2 except G␤ 5 ␥ 2 activate AC type II and inhibit AC type I (19, 20) . The present study demonstrates that G␤␥-subunits released by activation of G i/o -coupled receptors activate both AC type II and PLC-␤2. Because our experiments were performed with the Xenopus oocyte expression system without expression of any G protein subunits, the expressed G i/o -coupled receptors in oocytes used endogenously expressed G proteins. Thus the combination of G␤ and G␥ subunits responsible for such signaling pathways remains to be elucidated. Further studies are necessary to determine the combinations of G␤ and G␥ that are responsible for cellular signaling pathways activated by G i/o -coupled receptors.
Previous studies reported that some G i/o -coupled receptormediated effects were diverse and closely correlated to biological and biomedical effects. Analgesic -opioid receptors couple to G i/o proteins to inhibit AC activity, but they stimulate AC activity under certain circumstances. In a study measuring paw withdrawal thresholds to mechanical stimuli in SpragueDawley rats, Khasar et al. (17) -ol]-enkephalin (DAMGO) attenuated hyperalgesia induced by prostaglandin E 2 (PGE 2 ), an agonist of G s -coupled PGE 2 receptors. On the other hand, postadministration of DAMGO just after PGE 2 administration enhanced PGE 2 -induced hyperalgesia. Khasar et al. concluded that the DAMGO-induced enhancement was mediated by G␤␥ from G i/o -coupled -opioid receptors and activated PGE 2 receptors. Yao et al. (32) showed that ethanol consumption in the rat could be mediated by activation of cAMP-dependent protein kinases by synergistic stimulation of G␤␥-subunits released from G i/o -coupled dopamine type 2 receptors and activation of G s -coupled aden- Fig. 9 . Pretreatment with PTX and coexpression of Gt␣ abrogates 5-HT-or DADLE-induced inward currents. 5-HT (10 Ϫ7 M) and DADLE (10 Ϫ7 M) were applied for 30 s. The currents were measured in oocytes expressing 5-HT1AR and PLC-␤2 (5-HT1AR ϩ PLC-␤2) or ␦-opioid receptor and PLC-␤2 (␦-opioidR ϩ PLC-␤2). A, left: representative traces of inward currents from these oocytes pretreated with 2 g/ml PTX (ϩPTX) or without PTX (ϪPTX) for 16 h; right: representative traces of inward currents from these oocytes coexpressing Gt␣ (ϩGt␣) or not expressing Gt␣ (ϪGt␣). B: summary of effects of PTX treatment or Gt␣ coexpression on the currents. Each bar represents the mean Ϯ SE of peak Cl Ϫ currents from each of 6 oocytes.
osine type 2 receptors, both of which were induced by having the rats drink ethanol. In another study at the same laboratory, Yao et al. (33) reported that some addictive effects caused by activation of ␦-opioid or cannabinoid CB 1 receptors were possibly due to enhanced activation of cAMP-dependent kinases by a synergy of such G i/o -coupled ␦-opioid or CB 1 receptors with adenosine type 2 receptors. Yao and coworkers proposed that drugs that target G␤␥-subunits or the synergy of several G i/o -coupled receptors with adenosine type 2 receptors might prevent or attenuate excessive drinking of ethanol and the addictive effects of ethanol and other drugs (32, 33) . The present results and further experimental studies should clarify the roles of G␤␥-subunits in such physiological phenomena.
In conclusion, using a set of cloned G i/o -coupled receptors, we have demonstrated that G␤␥-subunits liberated by activation of G i/o -coupled receptors are involved in diverse signaling pathways such as enhancement of cAMP pathways and intracellular Ca 2ϩ mobilization.
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